VANGUARD GROUP INC - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is and the CUSIP is 834203309. A total of 21 filers reported holding SOLENO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,630,457
+661.0%
55,251
+10.6%
0.00%
Q2 2023$214,238
+100.5%
49,9390.0%0.00%
Q1 2023$106,869
+8.1%
49,9390.0%0.00%
Q4 2022$98,879
-51.0%
49,939
-58.8%
0.00%
Q3 2022$202,000121,0860.00%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 422,489$904,1270.33%
Clayton Partners LLC 92,772$198,5320.19%
Nantahala Capital Management 699,364$1,496,6390.12%
Worth Venture Partners, LLC 103,913$222,3740.11%
Carlyle Group Inc. 1,201,506$2,535,1780.08%
J. Goldman & Co LP 269,443$576,6080.02%
BANK OF AMERICA CORP /DE/ 2,093$4,4790.00%
WELLS FARGO & COMPANY/MN 38$810.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 37$790.00%
View complete list of SOLENO THERAPEUTICS INC shareholders